<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.0 20120330//EN" "JATS-archivearticle1.dtd">
<article xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="review-article"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">J Stroke</journal-id><journal-id journal-id-type="iso-abbrev">J Stroke</journal-id><journal-id journal-id-type="publisher-id">JOS</journal-id><journal-title-group><journal-title>Journal of Stroke</journal-title></journal-title-group><issn pub-type="ppub">2287-6391</issn><issn pub-type="epub">2287-6405</issn><publisher><publisher-name>Korean Stroke Society</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">26846757</article-id><article-id pub-id-type="pmc">4747064</article-id><article-id pub-id-type="doi">10.5853/jos.2015.01739</article-id><article-id pub-id-type="publisher-id">jos-2015-01739</article-id><article-categories><subj-group subj-group-type="heading"><subject>Special Review</subject></subj-group></article-categories><title-group><article-title>Moyamoya Disease: Treatment and Outcomes</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Kim</surname><given-names>Tackeun</given-names></name><xref ref-type="aff" rid="af1-jos-2015-01739"><sup>a</sup></xref><xref ref-type="aff" rid="af2-jos-2015-01739"><sup>b</sup></xref></contrib><contrib contrib-type="author"><name><surname>Oh</surname><given-names>Chang Wan</given-names></name><xref ref-type="corresp" rid="c1-jos-2015-01739"/><xref ref-type="aff" rid="af1-jos-2015-01739"><sup>a</sup></xref><xref ref-type="aff" rid="af2-jos-2015-01739"><sup>b</sup></xref></contrib><contrib contrib-type="author"><name><surname>Bang</surname><given-names>Jae Seung</given-names></name><xref ref-type="aff" rid="af1-jos-2015-01739"><sup>a</sup></xref><xref ref-type="aff" rid="af2-jos-2015-01739"><sup>b</sup></xref></contrib><contrib contrib-type="author"><name><surname>Kim</surname><given-names>Jeong Eun</given-names></name><xref ref-type="aff" rid="af2-jos-2015-01739"><sup>b</sup></xref><xref ref-type="aff" rid="af3-jos-2015-01739"><sup>c</sup></xref></contrib><contrib contrib-type="author"><name><surname>Cho</surname><given-names>Won-Sang</given-names></name><xref ref-type="aff" rid="af2-jos-2015-01739"><sup>b</sup></xref><xref ref-type="aff" rid="af3-jos-2015-01739"><sup>c</sup></xref></contrib><aff id="af1-jos-2015-01739"><label>a</label>Department of Neurosurgery, Seoul National University Bundang Hospital, Seongnam, <country>Korea</country></aff><aff id="af2-jos-2015-01739"><label>b</label>Department of Neurosurgery, Seoul National University College of Medicine, Seoul, <country>Korea</country></aff><aff id="af3-jos-2015-01739"><label>c</label>Department of Neurosurgery, Seoul National University Hospital, Seoul, <country>Korea</country></aff></contrib-group><author-notes><corresp id="c1-jos-2015-01739">Correspondence: Chang Wan Oh&#x02003; Department of Neurosurgery, Seoul National University Bundang Hospital, 82 Gumi-ro 173 Beon-gil, Bundang-gu, Seongnam 13620, Korea&#x02003; Tel: +82-31-787-7162 Fax: +82-31-787-4059 E-mail: <email>wanoh@snu.ac.kr</email></corresp></author-notes><pub-date pub-type="ppub"><month>1</month><year>2016</year></pub-date><pub-date pub-type="epub"><day>29</day><month>1</month><year>2016</year></pub-date><volume>18</volume><issue>1</issue><fpage>21</fpage><lpage>30</lpage><history><date date-type="received"><day>7</day><month>12</month><year>2015</year></date><date date-type="rev-recd"><day>17</day><month>1</month><year>2016</year></date><date date-type="accepted"><day>17</day><month>1</month><year>2016</year></date></history><permissions><copyright-statement>Copyright &#x000a9; 2016 Korean Stroke Society</copyright-statement><copyright-year>2016</copyright-year><license><license-p>This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by-nc/3.0/">http://creativecommons.org/licenses/by-nc/3.0/</ext-link>) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p></license></permissions><abstract><p>Although the pathogenesis of moyamoya disease (MMD) has not been fully elucidated, the effectiveness of surgical revascularization in preventing stroke has been addressed by many studies. The main mechanism of surgical revascularization is augmenting the intracranial blood flow using an external carotid system by either direct bypass or pial synangiosis. This can improve resting cerebral blood flow as well as vascular reserve capacity. For direct revascularization, the superficial temporal artery is used as the donor artery in most cases, although the occipital artery may be used in limited cases. Usually, the cortical branch of the middle cerebral artery is selected as the recipient of direct anastomosis. As for indirect revascularization, various techniques using different kinds of connective tissues have been introduced. In some cases, reinforcing the anterior cerebral artery and the posterior cerebral artery territories can be considered. The effectiveness of surgical revascularization for preventing ischemic stroke had been generally accepted by many studies. However, for preventing hemorrhagic stroke, new evidence has been added by a recent randomized controlled trial. The incidence of peri-operative complications such as stroke and hyperperfusion syndrome seems to be high due to the nature of the disease and technical demands for treatment. Preventing and adequately managing these complications are essential for ensuring the benefits of surgery.</p></abstract><kwd-group><kwd>Moyamoya disease</kwd><kwd>Cerebral revascularization</kwd><kwd>Treatment outcome</kwd></kwd-group></article-meta></front><body><sec sec-type="intro"><title>Introduction</title><p>Moyamoya disease (MMD) is an idiopathic disease with a progressive nature leading to recurrent stroke due to occlusion of the terminal internal carotid arteries [<xref rid="b1-jos-2015-01739" ref-type="bibr">1</xref>]. Although a recent genetic study identified a possible susceptibility gene [<xref rid="b2-jos-2015-01739" ref-type="bibr">2</xref>], the pathogenesis of MMD has not been fully defined. Nevertheless, the incidence and prevalence of MMD has gradually increased [<xref rid="b3-jos-2015-01739" ref-type="bibr">3</xref>]. Revascularization surgery for symptomatic MMD is considered the standard treatment for preventing further stroke [<xref rid="b4-jos-2015-01739" ref-type="bibr">4</xref>,<xref rid="b5-jos-2015-01739" ref-type="bibr">5</xref>]. The main objective of surgery is to augment intracranial blood flow using an external carotid system by either direct bypass or pial synangiosis. Although this phenomenon is a natural adaption process for compensating for stenosis of the internal carotid artery (ICA), it can be achieved readily by either extracranial-intracranial bypass or vasculogenesis using indirect pial synangiosis for symptomatic patients. In particular, surgical revascularization to prevent ischemic stroke is an effective treatment for patients with MMD with an ischemic presentation [<xref rid="b6-jos-2015-01739" ref-type="bibr">6</xref>]. Although still controversial, revascularization surgery to prevent further hemorrhage has also been performed by many neurosurgeons [<xref rid="b7-jos-2015-01739" ref-type="bibr">7</xref>]. Recently, an endovascular treatment has also been introduced through embolization of a ruptured aneurysm of the collateral vessels and angioplasty of a narrowed segment with or without stenting [<xref rid="b8-jos-2015-01739" ref-type="bibr">8</xref>,<xref rid="b9-jos-2015-01739" ref-type="bibr">9</xref>].</p></sec><sec><title>Conservative treatment of MMD</title><p>Long-term prognosis for patients with non-surgically treated MMD is not fully understood. However, some reports have described its natural clinical course and the results of conservative treatment. Kuroda et al. [<xref rid="b10-jos-2015-01739" ref-type="bibr">10</xref>] reported a disease progression rate of approximately 20% over 6 years. Being female was identified as an independent risk factor for disease progression by multivariate analysis. Other investigations on the progression rate of the unaffected side of surgically treated unilateral MMD reported that six of the 41 cases (14.6%) exhibited contralateral progression during the mean follow-up of 34 months [<xref rid="b11-jos-2015-01739" ref-type="bibr">11</xref>]. Considering these reports, MMD seems to have a progressive nature. Among many studies examining risk factors for MMD progression, the presence of thyroid disease such as Graves&#x02019; disease has been a well-known medical condition linked to rapid progression of MMD [<xref rid="b12-jos-2015-01739" ref-type="bibr">12</xref>,<xref rid="b13-jos-2015-01739" ref-type="bibr">13</xref>]. Recently, the <italic>RNF213</italic> variant was suggested as a possible causative genetic alteration leading to the development as well as progression of MMD [<xref rid="b14-jos-2015-01739" ref-type="bibr">14</xref>].</p><p>Because surgical revascularization has been recommended for symptomatic patients with impaired hemodynamics, some studies have described the outcomes of conservative treatment among asymptomatic or hemodynamically stable patients with MMD. A multi-center, nationwide survey for conservative treatment results was conducted in 2007 in Japan. The authors reported the annual stroke rate as 3.2% from the observation of 34 asymptomatic patients conservatively followed over 44 months. Hemodynamic disturbance was revealed to be a risk factor for newly developed stroke [<xref rid="b15-jos-2015-01739" ref-type="bibr">15</xref>]. In a North American series, the rates of annual ischemic and hemorrhagic stroke rate were reported as 13.3% and 1.7%, respectively. Being female and smoking were risk factors for stroke development [<xref rid="b16-jos-2015-01739" ref-type="bibr">16</xref>]. Cho et al. reported an annual stroke rate of 4.5% among 241 hemodynamically stable patients with MMD over 83 months. The annual stroke rate was higher in the hemorrhagic presentation group (5.7%) than the ischemic presentation group (4.2%) or the asymptomatic group (3.4%). They found familial disease and thyroid disease to be risk factors affecting stroke occurrence [<xref rid="b17-jos-2015-01739" ref-type="bibr">17</xref>]. As for ischemic presenting MMD, 5.6% of the annual ischemic stroke rate also reported that posterior circulation involvement was a strong risk factor for ischemic stroke [<xref rid="b18-jos-2015-01739" ref-type="bibr">18</xref>].</p><p>Antiplatelet treatment for preventing stroke in patients with MMD had been utilized by many physicians, especially in non-Asian areas. According to the reports of a worldwide survey, 31% of responders agreed to use long-term acetylsalicylic acid [<xref rid="b19-jos-2015-01739" ref-type="bibr">19</xref>]. However, the evidence for antiplatelet treatment is lacking. Recently, the efficacy of antiplatelet therapy for preventing stroke was investigated in a cohort study with a large sample size. According to the authors, antiplatelet therapy could not prevent recurrent cerebral infarction for ischemic presenting patients with MMD. The nature of the ischemic insult in patients with MMD is not an embolic infarction, but instead is mainly a hemodynamic infarction. The pathologic changes of the MMD vessels near the ICA bifurcation are not a type of endothelial damage, which is prone to platelet adhesion. Therefore, theoretically, antiplatelet drugs will not be effective for preventing ischemic stroke in patients with MMD. Although antiplatelet users are subject to hemorrhagic complications, the therapy was not associated with an increase in cerebral hemorrhage among patients with MMD [<xref rid="b20-jos-2015-01739" ref-type="bibr">20</xref>]. Thus, prescribing antiplatelet agents for symptomatic patients with MMD should not yet be considered as an alternative treatment.</p></sec><sec><title>Indication of surgical revascularization for MMD</title><p>The most important goal of surgical revascularization is to prevent cerebral infarction by improving cerebral blood flow (CBF) and restoring reserve capacity. Generally accepted indications for revascularization include recurrent clinical symptoms due to 1) apparent cerebral ischemia or 2) decreased regional CBF, vascular response, and reserve in perfusion studies [<xref rid="b4-jos-2015-01739" ref-type="bibr">4</xref>]. However, this cannot be strictly applied to all patients due to the different clinical course between pediatric and adult patients with MMD. Since pediatric MMD is characteristically more progressive than in adult patients, revascularization surgery is indicated in most children with MMD [<xref rid="b21-jos-2015-01739" ref-type="bibr">21</xref>]. As such, it is very important that early diagnosis and active intervention happen before irreversible brain damage occurs in order to achieve a favorable clinical outcome in children [<xref rid="b22-jos-2015-01739" ref-type="bibr">22</xref>].</p><p>As described earlier, the stroke incidence in asymptomatic patients with MMD or MMD with a relatively stable hemodynamic status seems to be significant. To determine a treatment strategy for these patients, several factors should be considered and shared with the patient. In the case of crescendo TIA, surgical treatment should be considered even if the hemodynamic status is nearly normal. Since the benefit-risk difference is narrow and mostly dependent on peri-operative complications, a critical consideration in selecting surgery is the complication profile of the surgeon and institute [<xref rid="b6-jos-2015-01739" ref-type="bibr">6</xref>].</p></sec><sec><title>Statistics of surgical revascularization for MMD</title><p>To our knowledge, national statistics regarding surgical treatment for MMD have not been published. According to the database of the National Health Insurance Service, a universal insurer in Korea, 10,506 patients were newly diagnosed with MMD between 2009 and 2013 [<xref rid="b3-jos-2015-01739" ref-type="bibr">3</xref>]. During the same period, 3,326 revascularization surgeries were performed in Korea. Among those surgical procedures, 2,157 (64.8%) were direct (including combined) and 1,169 (35.1%) were indirect surgery. As a crude calculation, this suggests that 31.4% of newly diagnosed patients with MMD were treated using surgical modalities. Throughout this period, the number of direct revascularization surgeries has gradually increased while the number of indirect revascularization surgeries has remained stagnant (<xref rid="f1-jos-2015-01739" ref-type="fig">Figure 1</xref>).</p></sec><sec><title>Direct revascularization for MMD</title><p>Since the 1970s, direct bypass has been used in patients with MMD [<xref rid="b23-jos-2015-01739" ref-type="bibr">23</xref>]. Following successful anastomosis between donor and recipient arteries, improvement in flow is achieved immediately after surgery [<xref rid="b24-jos-2015-01739" ref-type="bibr">24</xref>]. However, this procedure is technically difficult, requiring a highly trained surgeon. The vascular diameters of the superficial temporal artery (STA) and cortical arteries are important factors to determine the possibility of a direct bypass. In the advanced stage of MMD, most of the cortical arteries have shrunk to a small caliber and the vessel walls of patients with MMD tend to be more fragile. Post-operative hyperperfusion syndrome is another considerable problem leading to neurologic deterioration, which often develops after direct bypass surgery.</p><p>As a donor artery, the STA is selected in the majority of cases (<xref rid="f2-jos-2015-01739" ref-type="fig">Figure 2</xref>, black arrowheads) [<xref rid="b6-jos-2015-01739" ref-type="bibr">6</xref>,<xref rid="b24-jos-2015-01739" ref-type="bibr">24</xref>-<xref rid="b29-jos-2015-01739" ref-type="bibr">29</xref>]. After harvesting the STA from the scalp, papaverine is applied to the surface of the STA to prevent vasospasm. Various craniotomies can be performed according to the surgeon&#x02019;s preference and region of hypoperfusion. In addition, naturally formed trans-dural or trans-calvarial collateral channels should be preserved without injury. Most recipients are cortical branches of the middle cerebral artery (MCA, <xref rid="f2-jos-2015-01739" ref-type="fig">Figure 2</xref>, white arrowheads). The Chater&#x02019;s point is a useful landmark for identifying the larger cortical branches. To reinforce posterior cerebral artery (PCA) blood flow, the occipital artery (OA) has been used as a donor for anastomosis to the PCA cortical branch [<xref rid="b30-jos-2015-01739" ref-type="bibr">30</xref>]. Of note, various indirect revascularization methods are combined in most cases.</p><p>The amount of blood flow through the bypass pedicle can be measured with an ultrasonic flow meter and visualized by indocyanine green angiography [<xref rid="b31-jos-2015-01739" ref-type="bibr">31</xref>]. During the follow-up period, digital subtraction with angiography and quantitative magnetic resonance angiography is useful to evaluate the patency and the amount of bypass flow (<xref rid="f3-jos-2015-01739" ref-type="fig">Figure 3</xref>).</p></sec><sec><title>Indirect revascularization for MMD</title><p>As described, direct bypass is a somewhat difficult procedure in young pediatric patients or adult patients with advanced MMD due to the small caliber of the recipient artery. In such cases, fortunately, indirect bypass using various connective tissues has been effective, possibly due to the nature of the disease in promoting spontaneous leptomeningeal collateral formation [<xref rid="b32-jos-2015-01739" ref-type="bibr">32</xref>]. The one of advantage of indirect revascularization is that it is relatively easier to perform than direct surgery. This makes the operation time shorter, which is important in preventing complications. In addition, post-operative hyperperfusion syndrome rarely develops after indirect revascularization. However, it takes more time to improve cerebral blood flow, because neovascularization from connective tissue is not immediate.</p><p>The surgical procedures can be classified according to the various tissues covering the brain. Historically, encephalomyo synangiosis (EMS) for MMD was introduced by Karasawa et al. in the 1970s [<xref rid="b33-jos-2015-01739" ref-type="bibr">33</xref>]. In this operation, the deep temporal artery (DTA), supplying the temporalis muscle, becomes the main supplier of neovascularization. The temporalis muscle or dissected inner fascia can be covered with the brain surface being sutured with dura. Of note, swollen muscle can cause brain compression after surgery.</p><p>In an encephalo-duro-arterio synangiosis (EDAS) operation, a skin incision is usually made along the parietal branch of the STA. After harvesting the STA with the surrounding galea and periosteum, craniotomy and durotomy are made under the STA flap with a galea cuff. Each margin of the dura and galea are sutured together to cover the brain with an arterial flap. Typically, the STA is connected to both the proximal and distal side (<xref rid="f4-jos-2015-01739" ref-type="fig">Figure 4</xref>).</p><p>Other indirect methods such as encephalo-myo-arterio synangiosis (EMAS), encephalo-duro-arterio-myo synangiosis (EDAMS), and encephalo-galeo synangiosis (EGS) are performed as variants of EMS and EDAS [<xref rid="b33-jos-2015-01739" ref-type="bibr">33</xref>-<xref rid="b38-jos-2015-01739" ref-type="bibr">38</xref>].</p><p>Bi-frontal indirect bypass can be considered if the patient has frontal lobar hypoperfusion [<xref rid="b39-jos-2015-01739" ref-type="bibr">39</xref>-<xref rid="b42-jos-2015-01739" ref-type="bibr">42</xref>]. In MMD, the diameter of the frontal branch of the STA becomes thin and branched at the midline. Thus, without a large artery, the galea and the periosteum are important sources for indirect revascularization in this area. After harvesting the galeo-periosteal flap, a craniotomy crossing the midline is made on the frontal cranium. The dura is incised leaving a base for the superior sagittal sinus, followed by folding the dura into the hemispheric fissure if possible [<xref rid="b39-jos-2015-01739" ref-type="bibr">39</xref>]. The galeo-periosteal flap is sutured with incised dura margins to cover the frontal brain.</p><p>Since the cortical branches of the PCA are usually smaller in caliber, the use of an indirect bypass for PCA territories has also been well described [<xref rid="b43-jos-2015-01739" ref-type="bibr">43</xref>,<xref rid="b44-jos-2015-01739" ref-type="bibr">44</xref>]. The occipital artery is used as a supply vessel in this and other procedures that are similar to EDAS. Additional techniques include omental flap surgery and multiple burr hole surgery, which have also been introduced as either primary or rescue surgeries after failed revascularization. Despite relatively few reports, neovascularization with these methods has been reported to be comparable to other methods [<xref rid="b45-jos-2015-01739" ref-type="bibr">45</xref>-<xref rid="b48-jos-2015-01739" ref-type="bibr">48</xref>].</p></sec><sec><title>Perioperative complications</title><p>Various studies have reported complications after revascularization surgery for MMD. Postoperative stroke with permanent neurologic deficits developed in 1.6%-16.0% [<xref rid="b6-jos-2015-01739" ref-type="bibr">6</xref>,<xref rid="b24-jos-2015-01739" ref-type="bibr">24</xref>,<xref rid="b26-jos-2015-01739" ref-type="bibr">26</xref>-<xref rid="b28-jos-2015-01739" ref-type="bibr">28</xref>] of patients and was more frequent in adults than in pediatric patients [<xref rid="b49-jos-2015-01739" ref-type="bibr">49</xref>]. In addition, permanent neurologic deficits developed in 0.9%-8.0% of those with peri-operative ischemic stroke [<xref rid="b6-jos-2015-01739" ref-type="bibr">6</xref>,<xref rid="b24-jos-2015-01739" ref-type="bibr">24</xref>,<xref rid="b26-jos-2015-01739" ref-type="bibr">26</xref>,<xref rid="b27-jos-2015-01739" ref-type="bibr">27</xref>]. However, the radiologic incidence of ischemic stroke was higher than symptomatic stroke. Funaki et al. reported that postoperative diffusion weighted imaging (DWI)-defined lesions were detected in 13 (9.3%) out of 140 direct bypass operations for MMD, although only four lesions (2.9%) could be classified as a permanent complication. However, the incidence of postoperative DWI-detected lesions in the unstable group was significant at 33.3% (8 of 24) [<xref rid="b50-jos-2015-01739" ref-type="bibr">50</xref>]. These peri-operative ischemic complications can be caused by several factors. However, the most important factor is the hemodynamic status of the patients. A patient with an advanced Suzuki stage with a lower CBF is prone to intraoperative stroke development. During surgery, maintaining euvolemic status and the appropriate blood pressure are important, along with appropriate anesthetic care. In addition, both hypotension and hypercapnia can aggravate hypoperfusion during surgery. Maintaining the level of hemoglobin is also essential in for oxygen delivery capacity. Thus, it is very important to communicate with the anesthesiologist while planning revascularization surgery.</p><p>Hemorrhagic stroke leading to permanent disability as a complication of revascularization for MMD developed in 0.7%-8.0% of patients in previous studies [<xref rid="b6-jos-2015-01739" ref-type="bibr">6</xref>,<xref rid="b24-jos-2015-01739" ref-type="bibr">24</xref>,<xref rid="b26-jos-2015-01739" ref-type="bibr">26</xref>-<xref rid="b28-jos-2015-01739" ref-type="bibr">28</xref>]. Postoperative epidural hematoma (EDH) requiring surgical treatment developed in 4.8% of pediatric patients with MMD, which was significantly higher than for non-MMD craniotomies (0.8%, <italic>P</italic>&#x0003c;0.001) [<xref rid="b51-jos-2015-01739" ref-type="bibr">51</xref>]. Controlling immediate postoperative stroke is the most important factor in securing the benefit of revascularization surgery for MMD, because most incidences of stroke develop in the immediate postoperative period [<xref rid="b6-jos-2015-01739" ref-type="bibr">6</xref>].</p><p>Another well-known phenomenon causing postoperative neurologic changes is hyperperfusion syndrome (21.5%-50.0%) [<xref rid="b52-jos-2015-01739" ref-type="bibr">52</xref>-<xref rid="b55-jos-2015-01739" ref-type="bibr">55</xref>]. This phenomenon characteristically presents with transient neurologic deterioration with increased blood flow, and mostly develops in patients with MMD after surgery [<xref rid="b55-jos-2015-01739" ref-type="bibr">55</xref>]. Several possible mechanisms of hyperperfusion syndrome have been suggested. Due to a decreased vascular reserve capacity, the auto-regulatory function of the cerebral arteries in patients with MMD is severely impaired. After direct bypass, an increased amount of blood flows through these impaired arteries that cannot regulate the excessive flow [<xref rid="b56-jos-2015-01739" ref-type="bibr">56</xref>]. Moreover, due to chronic ischemia, vascular permeability is increased in vessels of patients with MMD [<xref rid="b52-jos-2015-01739" ref-type="bibr">52</xref>]. Although some reports introduced the idea of lowering systemic blood pressure as treatment for hyperperfusion syndrome [<xref rid="b56-jos-2015-01739" ref-type="bibr">56</xref>], it can cause ischemic stroke because hyperperfusion is a local phenomenon associated with global hypoperfusion. Rather, adequate use of fluids and maintaining systemic blood pressure according to pre-operative levels are important for preventing further damage from ischemic or hemorrhagic stroke.</p><p>During surgery, the arteries of the scalp (i.e. STA and OA) are harvested and implanted into the intracranial space. This causes scalp ischemia that can lead to skin problems after revascularization. The incidence of scalp problems is reportedly 17.6%-21.4% [<xref rid="b57-jos-2015-01739" ref-type="bibr">57</xref>,<xref rid="b58-jos-2015-01739" ref-type="bibr">58</xref>]. Double-barrel procedures using both branches of the STA and a history of diabetes mellitus were found to be risk factors for wound-related complications [<xref rid="b58-jos-2015-01739" ref-type="bibr">58</xref>]. Moreover, a relationship between necrosis and smoking was noted [<xref rid="b57-jos-2015-01739" ref-type="bibr">57</xref>]. To prevent skin necrosis after revascularization, the margin of the skin incision should be preserved without coagulation for hemostasis. During skin closure, meticulous inspection is required to limit any excessive tension of suture materials.</p></sec><sec><title>Treatment outcomes</title><p>The most important role of surgery is preventing further stroke for patients with MMD. Although it has been rarely reported, conservatively managed patients with MMD experienced stroke at a rate ranging between 3.2%-15.0% annually [<xref rid="b15-jos-2015-01739" ref-type="bibr">15</xref>-<xref rid="b18-jos-2015-01739" ref-type="bibr">18</xref>]. In order to compare the stroke rate with the conservative group, reports regarding stroke development after surgical revascularization were reviewed. Among all studies, an annual incidence of post-operative stroke could be identified by surgical methods and age group (adult/pediatric) in 14 studies (<xref rid="t1-jos-2015-01739" ref-type="table">Table 1</xref>) [<xref rid="b6-jos-2015-01739" ref-type="bibr">6</xref>,<xref rid="b18-jos-2015-01739" ref-type="bibr">18</xref>,<xref rid="b24-jos-2015-01739" ref-type="bibr">24</xref>,<xref rid="b26-jos-2015-01739" ref-type="bibr">26</xref>,<xref rid="b59-jos-2015-01739" ref-type="bibr">59</xref>-<xref rid="b68-jos-2015-01739" ref-type="bibr">68</xref>].</p><p>Direct or combined revascularization for adult patients with MMD seems to be effective for preventing stroke [<xref rid="b6-jos-2015-01739" ref-type="bibr">6</xref>,<xref rid="b24-jos-2015-01739" ref-type="bibr">24</xref>,<xref rid="b26-jos-2015-01739" ref-type="bibr">26</xref>,<xref rid="b59-jos-2015-01739" ref-type="bibr">59</xref>,<xref rid="b64-jos-2015-01739" ref-type="bibr">64</xref>,<xref rid="b67-jos-2015-01739" ref-type="bibr">67</xref>]. Five studies with long term follow up (&#x0003e; 36 months) reported an annual stroke rate after direct revascularization of 0.0%-1.6% [<xref rid="b6-jos-2015-01739" ref-type="bibr">6</xref>,<xref rid="b24-jos-2015-01739" ref-type="bibr">24</xref>,<xref rid="b26-jos-2015-01739" ref-type="bibr">26</xref>,<xref rid="b59-jos-2015-01739" ref-type="bibr">59</xref>,<xref rid="b67-jos-2015-01739" ref-type="bibr">67</xref>]. Although Gross et al. reported a higher annual incidence (5.4%), their results may be due to a shorter follow-up duration. Since most post-operative stroke develops in the peri-operative period, careful interpretation of these results is required. Among these six studies, the weighted average of the annual stroke rate was 1.4% in 504 adult patients who underwent direct revascularization, which is noticeably lower than the conservative treatment results. The relative risk reduction for cerebral infarction by direct revascularization was reportedly 70.7% [<xref rid="b6-jos-2015-01739" ref-type="bibr">6</xref>].</p><p>Direct revascularization for pediatric patients with MMD may also be effective in preventing further stroke. Over a six-year follow-up period, six patients experienced post-operative stroke out of 190 pediatric patients who underwent direct revascularization. Especially, Kuroda et al. [<xref rid="b67-jos-2015-01739" ref-type="bibr">67</xref>] reported no stroke development during the 73 months following direct revascularization in pediatric patients with MMD. The weighted average of the annual stroke rate in three studies was 0.2% [<xref rid="b62-jos-2015-01739" ref-type="bibr">62</xref>,<xref rid="b66-jos-2015-01739" ref-type="bibr">66</xref>,<xref rid="b67-jos-2015-01739" ref-type="bibr">67</xref>]. These favorable outcomes could be achieved by improving CBF and vascular reserve capacity (<xref rid="f5-jos-2015-01739" ref-type="fig">Figure 5</xref>) [<xref rid="b25-jos-2015-01739" ref-type="bibr">25</xref>,<xref rid="b26-jos-2015-01739" ref-type="bibr">26</xref>,<xref rid="b69-jos-2015-01739" ref-type="bibr">69</xref>].</p><p>However, the incidence of newly developed cerebral infarction after indirect revascularization was reportedly somewhat higher than for the direct method. In reports examining adult cases treated with indirect revascularization, 0%-14.3% of patients annually experienced postoperative stroke [<xref rid="b18-jos-2015-01739" ref-type="bibr">18</xref>,<xref rid="b26-jos-2015-01739" ref-type="bibr">26</xref>,<xref rid="b59-jos-2015-01739" ref-type="bibr">59</xref>,<xref rid="b60-jos-2015-01739" ref-type="bibr">60</xref>,<xref rid="b64-jos-2015-01739" ref-type="bibr">64</xref>,<xref rid="b65-jos-2015-01739" ref-type="bibr">65</xref>]. The weighted average of annual stroke was 5.6% among 587 patients. On the other hand, indirect revascularization for pediatric patients with MMD seemed to be more effective than for adult patients. Four studies with a relatively longer follow-up (&#x0003e; 52 months) showed that the weighted average of annual stroke after indirect revascularization as 1.6% in pediatric cases [<xref rid="b61-jos-2015-01739" ref-type="bibr">61</xref>,<xref rid="b63-jos-2015-01739" ref-type="bibr">63</xref>,<xref rid="b65-jos-2015-01739" ref-type="bibr">65</xref>,<xref rid="b68-jos-2015-01739" ref-type="bibr">68</xref>]. Thus, indirect revascularization seems to be more effective in pediatric patients with MMD than in adults. In addition, surgically treated pediatric patients with MMD showed a comparable rate of good social adaptation [<xref rid="b70-jos-2015-01739" ref-type="bibr">70</xref>]. Nevertheless, the effectiveness of surgery for long-term protection of cognitive function is unclear even if the initial surgical treatment may result in good neurological outcomes [<xref rid="b71-jos-2015-01739" ref-type="bibr">71</xref>].</p><p>While the effectiveness of revascularization for ischemic MMD has been generally accepted, surgical indications for MMD with a hemorrhagic presentation also remain undetermined. In the 1980s, indirect revascularization was considered to be more effective for prevention of further hemorrhage than direct revascularization [<xref rid="b72-jos-2015-01739" ref-type="bibr">72</xref>]. However, Aoki reported unsatisfactory results for prevention of recurrent hemorrhage using indirect revascularization [<xref rid="b73-jos-2015-01739" ref-type="bibr">73</xref>]. Nevertheless, since 2010, the effectiveness of surgical revascularization for hemorrhagic MMD has been reported [<xref rid="b74-jos-2015-01739" ref-type="bibr">74</xref>]. Moreover, indirect revascularization for hemorrhagic MMD has shown effectiveness in pediatric patients [<xref rid="b75-jos-2015-01739" ref-type="bibr">75</xref>]. Jiang et al. reported a hemorrhage recurrence rate of 1.9% at two-year follow-up after direct revascularization in adult patients. The rate of hemorrhagic stroke development was estimated as 11.5% with conservative management in previous studies [<xref rid="b6-jos-2015-01739" ref-type="bibr">6</xref>,<xref rid="b7-jos-2015-01739" ref-type="bibr">7</xref>,<xref rid="b16-jos-2015-01739" ref-type="bibr">16</xref>,<xref rid="b17-jos-2015-01739" ref-type="bibr">17</xref>]. The level of evidence for prevention of further hemorrhage using direct revascularization became more robust in the Japan Adult Moyamoya Trial [<xref rid="b7-jos-2015-01739" ref-type="bibr">7</xref>]. However, this requires cautious interpretation because only marginal statistical significance was achieved by extensive bilateral direct revascularization.</p></sec><sec sec-type="conclusions"><title>Conclusion</title><p>Due to the progressive nature of the disease, surgical treatment for MMD should be considered for symptomatic patients. For pediatric patients, early diagnosis and active intervention before irreversible brain damage occurs are mandatory. Surgical revascularization is an effective treatment modality for preventing both ischemic and hemorrhagic stroke.</p></sec></body><back><fn-group><fn fn-type="conflict"><p>The authors have no financial conflicts of interest.</p></fn></fn-group><ref-list><title>References</title><ref id="b1-jos-2015-01739"><label>1</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Suzuki</surname><given-names>J</given-names></name><name><surname>Takaku</surname><given-names>A</given-names></name></person-group><article-title>Cerebrovascular &#x0201c;moyamoya&#x0201d; disease. Disease showing abnormal net-like vessels in base of brain</article-title><source>Arch Neurol</source><year>1969</year><volume>20</volume><fpage>288</fpage><lpage>299</lpage><pub-id pub-id-type="pmid">5775283</pub-id></element-citation></ref><ref id="b2-jos-2015-01739"><label>2</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fujimura</surname><given-names>M</given-names></name><name><surname>Sonobe</surname><given-names>S</given-names></name><name><surname>Nishijima</surname><given-names>Y</given-names></name><name><surname>Niizuma</surname><given-names>K</given-names></name><name><surname>Sakata</surname><given-names>H</given-names></name><name><surname>Kure</surname><given-names>S</given-names></name><etal/></person-group><article-title>Genetics and Biomarkers of Moyamoya Disease: significance of RNF213 as a Susceptibility Gene</article-title><source>J Stroke</source><year>2014</year><volume>16</volume><fpage>65</fpage><lpage>72</lpage><pub-id pub-id-type="pmid">24949311</pub-id></element-citation></ref><ref id="b3-jos-2015-01739"><label>3</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kim</surname><given-names>T</given-names></name><name><surname>Lee</surname><given-names>H</given-names></name><name><surname>Bang</surname><given-names>JS</given-names></name><name><surname>Kwon</surname><given-names>OK</given-names></name><name><surname>Hwang</surname><given-names>G</given-names></name><name><surname>Oh</surname><given-names>CW</given-names></name></person-group><article-title>Epidemiology of Moyamoya Disease in Korea: based on National Health Insurance Service Data</article-title><source>J Korean Neurosurg Soc</source><year>2015</year><volume>57</volume><fpage>390</fpage><lpage>395</lpage><pub-id pub-id-type="pmid">26180604</pub-id></element-citation></ref><ref id="b4-jos-2015-01739"><label>4</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fukui</surname><given-names>M</given-names></name></person-group><article-title>Guidelines for the diagnosis and treatment of spontaneous occlusion of the circle of Willis (&#x02018;moyamoya&#x02019; disease). Research Committee on Spontaneous Occlusion of the Circle of Willis (Moyamoya Disease) of the Ministry of Health and Welfare, Japan</article-title><source>Clin Neurol Neurosurg</source><year>1997</year><volume>99</volume><issue>Suppl 2</issue><fpage>S238</fpage><lpage>240</lpage><pub-id pub-id-type="pmid">9409446</pub-id></element-citation></ref><ref id="b5-jos-2015-01739"><label>5</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Narisawa</surname><given-names>A</given-names></name><name><surname>Fujimura</surname><given-names>M</given-names></name><name><surname>Tominaga</surname><given-names>T</given-names></name></person-group><article-title>Efficacy of the revascularization surgery for adult-onset moyamoya disease with the progression of cerebrovascular lesions</article-title><source>Clin Neurol Neurosurg</source><year>2009</year><volume>111</volume><fpage>123</fpage><lpage>126</lpage><pub-id pub-id-type="pmid">18995956</pub-id></element-citation></ref><ref id="b6-jos-2015-01739"><label>6</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kim</surname><given-names>T</given-names></name><name><surname>Oh</surname><given-names>CW</given-names></name><name><surname>Kwon</surname><given-names>OK</given-names></name><name><surname>Hwang</surname><given-names>G</given-names></name><name><surname>Kim</surname><given-names>JE</given-names></name><name><surname>Kang</surname><given-names>HS</given-names></name><etal/></person-group><article-title>Stroke prevention by direct revascularization for patients with adult-onset moyamoya disease presenting with ischemia</article-title><source>J Neurosurg</source><year>2015</year><fpage>1</fpage><lpage>6</lpage></element-citation></ref><ref id="b7-jos-2015-01739"><label>7</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Miyamoto</surname><given-names>S</given-names></name><name><surname>Yoshimoto</surname><given-names>T</given-names></name><name><surname>Hashimoto</surname><given-names>N</given-names></name><name><surname>Okada</surname><given-names>Y</given-names></name><name><surname>Tsuji</surname><given-names>I</given-names></name><name><surname>Tominaga</surname><given-names>T</given-names></name><etal/></person-group><article-title>Effects of extracranial-intracranial bypass for patients with hemorrhagic moyamoya disease: results of the Japan Adult Moyamoya Trial</article-title><source>Stroke</source><year>2014</year><volume>45</volume><fpage>1415</fpage><lpage>1421</lpage><pub-id pub-id-type="pmid">24668203</pub-id></element-citation></ref><ref id="b8-jos-2015-01739"><label>8</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kim</surname><given-names>SH</given-names></name><name><surname>Kwon</surname><given-names>OK</given-names></name><name><surname>Jung</surname><given-names>CK</given-names></name><name><surname>Kang</surname><given-names>HS</given-names></name><name><surname>Oh</surname><given-names>CW</given-names></name><name><surname>Han</surname><given-names>MH</given-names></name><etal/></person-group><article-title>Endovascular treatment of ruptured aneurysms or pseudoaneurysms on the collateral vessels in patients with moyamoya disease</article-title><source>Neurosurgery</source><year>2009</year><volume>65</volume><fpage>1000</fpage><lpage>1004</lpage><pub-id pub-id-type="pmid">19834414</pub-id></element-citation></ref><ref id="b9-jos-2015-01739"><label>9</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kim</surname><given-names>T</given-names></name><name><surname>Kwon</surname><given-names>OK</given-names></name><name><surname>Oh</surname><given-names>CW</given-names></name><name><surname>Bang</surname><given-names>JS</given-names></name><name><surname>Hwang</surname><given-names>G</given-names></name><name><surname>Lee</surname><given-names>YJ</given-names></name></person-group><article-title>Intracranial stenting using a drug-eluting stent for moyamoya disease involving supraclinoid ICA: a case report</article-title><source>Neurol Med Chir (Tokyo)</source><year>2014</year><volume>54</volume><fpage>136</fpage><lpage>138</lpage><pub-id pub-id-type="pmid">24097093</pub-id></element-citation></ref><ref id="b10-jos-2015-01739"><label>10</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kuroda</surname><given-names>S</given-names></name><name><surname>Ishikawa</surname><given-names>T</given-names></name><name><surname>Houkin</surname><given-names>K</given-names></name><name><surname>Nanba</surname><given-names>R</given-names></name><name><surname>Hokari</surname><given-names>M</given-names></name><name><surname>Iwasaki</surname><given-names>Y</given-names></name></person-group><article-title>Incidence and clinical features of disease progression in adult moyamoya disease</article-title><source>Stroke</source><year>2005</year><volume>36</volume><fpage>2148</fpage><lpage>2153</lpage><pub-id pub-id-type="pmid">16179571</pub-id></element-citation></ref><ref id="b11-jos-2015-01739"><label>11</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lee</surname><given-names>SC</given-names></name><name><surname>Jeon</surname><given-names>JS</given-names></name><name><surname>Kim</surname><given-names>JE</given-names></name><name><surname>Chung</surname><given-names>YS</given-names></name><name><surname>Ahn</surname><given-names>JH</given-names></name><name><surname>Cho</surname><given-names>WS</given-names></name><etal/></person-group><article-title>Contralateral progression and its risk factor in surgically treated unilateral adult moyamoya disease with a review of pertinent literature</article-title><source>Acta Neurochir (Wien)</source><year>2014</year><volume>156</volume><fpage>103</fpage><lpage>111</lpage><pub-id pub-id-type="pmid">24201757</pub-id></element-citation></ref><ref id="b12-jos-2015-01739"><label>12</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kim</surname><given-names>SJ</given-names></name><name><surname>Heo</surname><given-names>KG</given-names></name><name><surname>Shin</surname><given-names>HY</given-names></name><name><surname>Bang</surname><given-names>OY</given-names></name><name><surname>Kim</surname><given-names>GM</given-names></name><name><surname>Chung</surname><given-names>CS</given-names></name><etal/></person-group><article-title>Association of thyroid autoantibodies with moyamoya-type cerebrovascular disease: a prospective study</article-title><source>Stroke</source><year>2010</year><volume>41</volume><fpage>173</fpage><lpage>176</lpage><pub-id pub-id-type="pmid">19926842</pub-id></element-citation></ref><ref id="b13-jos-2015-01739"><label>13</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Im</surname><given-names>SH</given-names></name><name><surname>Oh</surname><given-names>CW</given-names></name><name><surname>Kwon</surname><given-names>OK</given-names></name><name><surname>Kim</surname><given-names>JE</given-names></name><name><surname>Han</surname><given-names>DH</given-names></name></person-group><article-title>Moyamoya disease associated with Graves disease: special considerations regarding clinical significance and management</article-title><source>J Neurosurg</source><year>2005</year><volume>102</volume><fpage>1013</fpage><lpage>1017</lpage><pub-id pub-id-type="pmid">16028759</pub-id></element-citation></ref><ref id="b14-jos-2015-01739"><label>14</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mineharu</surname><given-names>Y</given-names></name><name><surname>Takagi</surname><given-names>Y</given-names></name><name><surname>Takahashi</surname><given-names>JC</given-names></name><name><surname>Hashikata</surname><given-names>H</given-names></name><name><surname>Liu</surname><given-names>W</given-names></name><name><surname>Hitomi</surname><given-names>T</given-names></name><etal/></person-group><article-title>Rapid progression of unilateral moyamoya disease in a patient with a family history and an RNF213 risk variant</article-title><source>Cerebrovasc Dis</source><year>2013</year><volume>36</volume><fpage>155</fpage><lpage>157</lpage><pub-id pub-id-type="pmid">24029639</pub-id></element-citation></ref><ref id="b15-jos-2015-01739"><label>15</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kuroda</surname><given-names>S</given-names></name><name><surname>Hashimoto</surname><given-names>N</given-names></name><name><surname>Yoshimoto</surname><given-names>T</given-names></name><name><surname>Iwasaki</surname><given-names>Y</given-names></name><collab>Research Committee on Moyamoya Disease in Japan</collab></person-group><article-title>Radiological findings, clinical course, and outcome in asymptomatic moyamoya disease: results of multicenter survey in Japan</article-title><source>Stroke</source><year>2007</year><volume>38</volume><fpage>1430</fpage><lpage>1435</lpage><pub-id pub-id-type="pmid">17395863</pub-id></element-citation></ref><ref id="b16-jos-2015-01739"><label>16</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gross</surname><given-names>BA</given-names></name><name><surname>Du</surname><given-names>R</given-names></name></person-group><article-title>The natural history of moyamoya in a North American adult cohort</article-title><source>J Clin Neurosci</source><year>2013</year><volume>20</volume><fpage>44</fpage><lpage>48</lpage><pub-id pub-id-type="pmid">23146211</pub-id></element-citation></ref><ref id="b17-jos-2015-01739"><label>17</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cho</surname><given-names>WS</given-names></name><name><surname>Chung</surname><given-names>YS</given-names></name><name><surname>Kim</surname><given-names>JE</given-names></name><name><surname>Jeon</surname><given-names>JP</given-names></name><name><surname>Son</surname><given-names>YJ</given-names></name><name><surname>Bang</surname><given-names>JS</given-names></name><etal/></person-group><article-title>The natural clinical course of hemodynamically stable adult moyamoya disease</article-title><source>J Neurosurg</source><year>2015</year><volume>122</volume><fpage>82</fpage><lpage>89</lpage><pub-id pub-id-type="pmid">25361479</pub-id></element-citation></ref><ref id="b18-jos-2015-01739"><label>18</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Noh</surname><given-names>HJ</given-names></name><name><surname>Kim</surname><given-names>SJ</given-names></name><name><surname>Kim</surname><given-names>JS</given-names></name><name><surname>Hong</surname><given-names>SC</given-names></name><name><surname>Kim</surname><given-names>KH</given-names></name><name><surname>Jun</surname><given-names>P</given-names></name><etal/></person-group><article-title>Long term outcome and predictors of ischemic stroke recurrence in adult moyamoya disease</article-title><source>J Neurol Sci</source><year>2015</year><volume>359</volume><fpage>381</fpage><lpage>388</lpage><pub-id pub-id-type="pmid">26671146</pub-id></element-citation></ref><ref id="b19-jos-2015-01739"><label>19</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kraemer</surname><given-names>M</given-names></name><name><surname>Berlit</surname><given-names>P</given-names></name><name><surname>Diesner</surname><given-names>F</given-names></name><name><surname>Khan</surname><given-names>N</given-names></name></person-group><article-title>What is the expert&#x02019;s option on antiplatelet therapy in moyamoya disease? Results of a worldwide Survey</article-title><source>Eur J Neurol</source><year>2012</year><volume>19</volume><fpage>163</fpage><lpage>167</lpage><pub-id pub-id-type="pmid">21771204</pub-id></element-citation></ref><ref id="b20-jos-2015-01739"><label>20</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yamada</surname><given-names>S</given-names></name><name><surname>Oki</surname><given-names>K</given-names></name><name><surname>Itoh</surname><given-names>Y</given-names></name><name><surname>Kuroda</surname><given-names>S</given-names></name><name><surname>Houkin</surname><given-names>K</given-names></name><name><surname>Tominaga</surname><given-names>T</given-names></name><etal/></person-group><article-title>Effects of Surgery and Antiplatelet Therapy in Ten-Year Follow-Up from the Registry Study of Research Committee on Moyamoya Disease in Japan</article-title><source>J Stroke Cerebrovasc Dis</source><year>2016</year><volume>25</volume><fpage>340</fpage><lpage>349</lpage><pub-id pub-id-type="pmid">26654669</pub-id></element-citation></ref><ref id="b21-jos-2015-01739"><label>21</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>KC</given-names></name><name><surname>Phi</surname><given-names>JH</given-names></name><name><surname>Lee</surname><given-names>JY</given-names></name><name><surname>Kim</surname><given-names>SK</given-names></name><name><surname>Cho</surname><given-names>BK</given-names></name></person-group><article-title>Indirect revascularization surgery for moyamoya disease in children and its special considerations</article-title><source>Korean J Pediatr</source><year>2012</year><volume>55</volume><fpage>408</fpage><lpage>413</lpage><pub-id pub-id-type="pmid">23227059</pub-id></element-citation></ref><ref id="b22-jos-2015-01739"><label>22</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kim</surname><given-names>SK</given-names></name><name><surname>Cho</surname><given-names>BK</given-names></name><name><surname>Phi</surname><given-names>JH</given-names></name><name><surname>Lee</surname><given-names>JY</given-names></name><name><surname>Chae</surname><given-names>JH</given-names></name><name><surname>Kim</surname><given-names>KJ</given-names></name><etal/></person-group><article-title>Pediatric moyamoya disease: An analysis of 410 consecutive cases</article-title><source>Ann Neurol</source><year>2010</year><volume>68</volume><fpage>92</fpage><lpage>101</lpage><pub-id pub-id-type="pmid">20582955</pub-id></element-citation></ref><ref id="b23-jos-2015-01739"><label>23</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Karasawa</surname><given-names>J</given-names></name><name><surname>Kikuchi</surname><given-names>H</given-names></name><name><surname>Furuse</surname><given-names>S</given-names></name><name><surname>Kawamura</surname><given-names>J</given-names></name><name><surname>Sakaki</surname><given-names>T</given-names></name></person-group><article-title>Treatment of moyamoya disease with STA-MCA anastomosis</article-title><source>J Neurosurg</source><year>1978</year><volume>49</volume><fpage>679</fpage><lpage>688</lpage><pub-id pub-id-type="pmid">712390</pub-id></element-citation></ref><ref id="b24-jos-2015-01739"><label>24</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cho</surname><given-names>WS</given-names></name><name><surname>Kim</surname><given-names>JE</given-names></name><name><surname>Kim</surname><given-names>CH</given-names></name><name><surname>Ban</surname><given-names>SP</given-names></name><name><surname>Kang</surname><given-names>HS</given-names></name><name><surname>Son</surname><given-names>YJ</given-names></name><etal/></person-group><article-title>Long-term outcomes after combined revascularization surgery in adult moyamoya disease</article-title><source>Stroke</source><year>2014</year><volume>45</volume><fpage>3025</fpage><lpage>3031</lpage><pub-id pub-id-type="pmid">25184359</pub-id></element-citation></ref><ref id="b25-jos-2015-01739"><label>25</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fujimura</surname><given-names>M</given-names></name><name><surname>Tominaga</surname><given-names>T</given-names></name></person-group><article-title>Lessons learned from moyamoya disease: outcome of direct/indirect revascularization surgery for 150 affected hemispheres</article-title><source>Neurol Med Chir (Tokyo)</source><year>2012</year><volume>52</volume><fpage>327</fpage><lpage>332</lpage><pub-id pub-id-type="pmid">22688070</pub-id></element-citation></ref><ref id="b26-jos-2015-01739"><label>26</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bang</surname><given-names>JS</given-names></name><name><surname>Kwon</surname><given-names>OK</given-names></name><name><surname>Kim</surname><given-names>JE</given-names></name><name><surname>Kang</surname><given-names>HS</given-names></name><name><surname>Park</surname><given-names>H</given-names></name><name><surname>Cho</surname><given-names>SY</given-names></name><etal/></person-group><article-title>Quantitative angiographic comparison with the OSIRIS program between the direct and indirect revascularization modalities in adult moyamoya disease</article-title><source>Neurosurgery</source><year>2012</year><volume>70</volume><fpage>625</fpage><lpage>632</lpage><pub-id pub-id-type="pmid">21866061</pub-id></element-citation></ref><ref id="b27-jos-2015-01739"><label>27</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Guzman</surname><given-names>R</given-names></name><name><surname>Lee</surname><given-names>M</given-names></name><name><surname>Achrol</surname><given-names>A</given-names></name><name><surname>Bell-Stephens</surname><given-names>T</given-names></name><name><surname>Kelly</surname><given-names>M</given-names></name><name><surname>Do</surname><given-names>HM</given-names></name><etal/></person-group><article-title>Clinical outcome after 450 revascularization procedures for moyamoya disease. Clinical article</article-title><source>J Neurosurg</source><year>2009</year><volume>111</volume><fpage>927</fpage><lpage>935</lpage><pub-id pub-id-type="pmid">19463046</pub-id></element-citation></ref><ref id="b28-jos-2015-01739"><label>28</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mesiwala</surname><given-names>AH</given-names></name><name><surname>Sviri</surname><given-names>G</given-names></name><name><surname>Fatemi</surname><given-names>N</given-names></name><name><surname>Britz</surname><given-names>GW</given-names></name><name><surname>Newell</surname><given-names>DW</given-names></name></person-group><article-title>Long-term outcome of superficial temporal artery-middle cerebral artery bypass for patients with moyamoya disease in the US</article-title><source>Neurosurg Focus</source><year>2008</year><volume>24</volume><fpage>E15</fpage><pub-id pub-id-type="pmid">18275291</pub-id></element-citation></ref><ref id="b29-jos-2015-01739"><label>29</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Miyamoto</surname><given-names>S</given-names></name><name><surname>Akiyama</surname><given-names>Y</given-names></name><name><surname>Nagata</surname><given-names>I</given-names></name><name><surname>Karasawa</surname><given-names>J</given-names></name><name><surname>Nozaki</surname><given-names>K</given-names></name><name><surname>Hashimoto</surname><given-names>N</given-names></name><etal/></person-group><article-title>Long-term outcome after STA-MCA anastomosis for moyamoya disease</article-title><source>Neurosurg Focus</source><year>1998</year><volume>5</volume><fpage>E5</fpage><pub-id pub-id-type="pmid">17112208</pub-id></element-citation></ref><ref id="b30-jos-2015-01739"><label>30</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hayashi</surname><given-names>T</given-names></name><name><surname>Shirane</surname><given-names>R</given-names></name><name><surname>Tominaga</surname><given-names>T</given-names></name></person-group><article-title>Additional surgery for postoperative ischemic symptoms in patients with moyamoya disease: the effectiveness of occipital artery-posterior cerebral artery bypass with an indirect procedure: technical case report</article-title><source>Neurosurgery</source><year>2009</year><volume>64</volume><fpage>E195</fpage><lpage>196</lpage><pub-id pub-id-type="pmid">19145147</pub-id></element-citation></ref><ref id="b31-jos-2015-01739"><label>31</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Amin-Hanjani</surname><given-names>S</given-names></name><name><surname>Du</surname><given-names>X</given-names></name><name><surname>Mlinarevich</surname><given-names>N</given-names></name><name><surname>Meglio</surname><given-names>G</given-names></name><name><surname>Zhao</surname><given-names>M</given-names></name><name><surname>Charbel</surname><given-names>FT</given-names></name></person-group><article-title>The cut flow index: an intraoperative predictor of the success of extracranial-intracranial bypass for occlusive cerebrovascular disease</article-title><source>Neurosurgery</source><year>2005</year><volume>56</volume><fpage>75</fpage><lpage>85</lpage><pub-id pub-id-type="pmid">15799795</pub-id></element-citation></ref><ref id="b32-jos-2015-01739"><label>32</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Matsushima</surname><given-names>T</given-names></name><name><surname>Fukui</surname><given-names>M</given-names></name><name><surname>Kitamura</surname><given-names>K</given-names></name><name><surname>Hasuo</surname><given-names>K</given-names></name><name><surname>Kuwabara</surname><given-names>Y</given-names></name><name><surname>Kurokawa</surname><given-names>T</given-names></name></person-group><article-title>Encephalo-duro-arterio-synangiosis in children with moyamoya disease</article-title><source>Acta Neurochir (Wien)</source><year>1990</year><volume>104</volume><fpage>96</fpage><lpage>102</lpage><pub-id pub-id-type="pmid">2251949</pub-id></element-citation></ref><ref id="b33-jos-2015-01739"><label>33</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Karasawa</surname><given-names>J</given-names></name><name><surname>Kikuchi</surname><given-names>H</given-names></name><name><surname>Furuse</surname><given-names>S</given-names></name><name><surname>Sakaki</surname><given-names>T</given-names></name><name><surname>Yoshida</surname><given-names>Y</given-names></name></person-group><article-title>A surgical treatment of &#x0201c;moyamoya&#x0201d; disease &#x0201c;encephalo-myo synangiosis&#x0201d;</article-title><source>Neurol Med Chir (Tokyo)</source><year>1977</year><volume>17</volume><fpage>29</fpage><lpage>37</lpage><pub-id pub-id-type="pmid">74029</pub-id></element-citation></ref><ref id="b34-jos-2015-01739"><label>34</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Matsushima</surname><given-names>Y</given-names></name></person-group><article-title>Encephalo-duro-arterio-synangiosis: surgical anatomy associated with procedure</article-title><source>No Shinkei Geka</source><year>1990</year><volume>18</volume><fpage>989</fpage><lpage>999</lpage><pub-id pub-id-type="pmid">2247204</pub-id></element-citation></ref><ref id="b35-jos-2015-01739"><label>35</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kinugasa</surname><given-names>K</given-names></name><name><surname>Mandai</surname><given-names>S</given-names></name><name><surname>Kamata</surname><given-names>I</given-names></name><name><surname>Sugiu</surname><given-names>K</given-names></name><name><surname>Ohmoto</surname><given-names>T</given-names></name></person-group><article-title>Surgical treatment of moyamoya disease: operative technique for encephalo-duro-arterio-myo-synangiosis, its follow-up, clinical results, and angiograms</article-title><source>Neurosurgery</source><year>1993</year><volume>32</volume><fpage>527</fpage><lpage>531</lpage><pub-id pub-id-type="pmid">8474642</pub-id></element-citation></ref><ref id="b36-jos-2015-01739"><label>36</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Irikura</surname><given-names>K</given-names></name><name><surname>Miyasaka</surname><given-names>Y</given-names></name><name><surname>Kurata</surname><given-names>A</given-names></name><name><surname>Tanaka</surname><given-names>R</given-names></name><name><surname>Yamada</surname><given-names>M</given-names></name><name><surname>Kan</surname><given-names>S</given-names></name><etal/></person-group><article-title>The effect of encephalo-myo-synangiosis on abnormal collateral vessels in childhood moyamoya disease</article-title><source>Neurol Res</source><year>2000</year><volume>22</volume><fpage>341</fpage><lpage>346</lpage><pub-id pub-id-type="pmid">10874680</pub-id></element-citation></ref><ref id="b37-jos-2015-01739"><label>37</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kawamoto</surname><given-names>H</given-names></name><name><surname>Kiya</surname><given-names>K</given-names></name><name><surname>Mizoue</surname><given-names>T</given-names></name><name><surname>Ohbayashi</surname><given-names>N</given-names></name></person-group><article-title>A modified burr-hole method &#x02018;galeoduroencephalosynangiosis&#x02019; in a young child with moyamoya disease. A preliminary report and surgical technique</article-title><source>Pediatr Neurosurg</source><year>2000</year><volume>32</volume><fpage>272</fpage><lpage>275</lpage><pub-id pub-id-type="pmid">10965275</pub-id></element-citation></ref><ref id="b38-jos-2015-01739"><label>38</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Takeuchi</surname><given-names>S</given-names></name><name><surname>Abe</surname><given-names>H</given-names></name><name><surname>Ozawa</surname><given-names>T</given-names></name><name><surname>Tanaka</surname><given-names>R</given-names></name></person-group><article-title>Surgical treatment for moyamoya disease. Surgical effect of encephalo-galeo-synangiosis on moyamoya disease</article-title><source>Surgery for Cerebral Strok</source><year>2000</year><volume>28</volume><fpage>98</fpage><lpage>103</lpage></element-citation></ref><ref id="b39-jos-2015-01739"><label>39</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kim</surname><given-names>CY</given-names></name><name><surname>Wang</surname><given-names>KC</given-names></name><name><surname>Kim</surname><given-names>SK</given-names></name><name><surname>Chung</surname><given-names>YN</given-names></name><name><surname>Kim</surname><given-names>HS</given-names></name><name><surname>Cho</surname><given-names>BK</given-names></name></person-group><article-title>Encephaloduroarteriosynangiosis with bifrontal encephalogaleo (periosteal) synangiosis in the pediatric moyamoya disease: the surgical technique and its outcomes</article-title><source>Childs Nerv Syst</source><year>2003</year><volume>19</volume><fpage>316</fpage><lpage>324</lpage><pub-id pub-id-type="pmid">12743718</pub-id></element-citation></ref><ref id="b40-jos-2015-01739"><label>40</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kim</surname><given-names>SK</given-names></name><name><surname>Wang</surname><given-names>KC</given-names></name><name><surname>Kim</surname><given-names>IO</given-names></name><name><surname>Lee</surname><given-names>DS</given-names></name><name><surname>Cho</surname><given-names>BK</given-names></name></person-group><article-title>Combined encephaloduroarteriosynangiosis and bifrontal encephalogaleo (periosteal) synangiosis in pediatric moyamoya disease</article-title><source>Neurosurgery</source><year>2002</year><volume>50</volume><fpage>88</fpage><lpage>96</lpage><pub-id pub-id-type="pmid">11844238</pub-id></element-citation></ref><ref id="b41-jos-2015-01739"><label>41</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Park</surname><given-names>JH</given-names></name><name><surname>Yang</surname><given-names>SY</given-names></name><name><surname>Chung</surname><given-names>YN</given-names></name><name><surname>Kim</surname><given-names>JE</given-names></name><name><surname>Kim</surname><given-names>SK</given-names></name><name><surname>Han</surname><given-names>DH</given-names></name><etal/></person-group><article-title>Modified encephaloduroarteriosynangiosis with bifrontal encephalogaleoperiosteal synangiosis for the treatment of pediatric moyamoya disease. Technical note</article-title><source>J Neurosurg</source><year>2007</year><volume>106</volume><fpage>237</fpage><lpage>242</lpage><pub-id pub-id-type="pmid">17465392</pub-id></element-citation></ref><ref id="b42-jos-2015-01739"><label>42</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Song</surname><given-names>YS</given-names></name><name><surname>Oh</surname><given-names>SW</given-names></name><name><surname>Kim</surname><given-names>YK</given-names></name><name><surname>Kim</surname><given-names>SK</given-names></name><name><surname>Wang</surname><given-names>KC</given-names></name><name><surname>Lee</surname><given-names>DS</given-names></name></person-group><article-title>Hemodynamic improvement of anterior cerebral artery territory perfusion induced by bifrontal encephalo(periosteal) synangiosis in pediatric patients with moyamoya disease: a study with brain perfusion SPECT</article-title><source>Ann Nucl Med</source><year>2012</year><volume>26</volume><fpage>47</fpage><lpage>57</lpage><pub-id pub-id-type="pmid">22033781</pub-id></element-citation></ref><ref id="b43-jos-2015-01739"><label>43</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kim</surname><given-names>DS</given-names></name><name><surname>Kye</surname><given-names>DK</given-names></name><name><surname>Cho</surname><given-names>KS</given-names></name><name><surname>Song</surname><given-names>JU</given-names></name><name><surname>Kang</surname><given-names>JK</given-names></name></person-group><article-title>Combined direct and indirect reconstructive vascular surgery on the frontoparieto-occipital region in moyamoya disease</article-title><source>Clin Neurol Neurosurg</source><year>1997</year><volume>99</volume><issue>Suppl 2</issue><fpage>S137</fpage><lpage>141</lpage><pub-id pub-id-type="pmid">9409424</pub-id></element-citation></ref><ref id="b44-jos-2015-01739"><label>44</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lee</surname><given-names>JY</given-names></name><name><surname>Kim</surname><given-names>SK</given-names></name><name><surname>Phi</surname><given-names>JH</given-names></name><name><surname>Wang</surname><given-names>KC</given-names></name></person-group><article-title>Posterior Cerebral Artery Insufficiency in Pediatric Moyamoya Disease</article-title><source>J Korean Neurosurg Soc</source><year>2015</year><volume>57</volume><fpage>436</fpage><lpage>439</lpage><pub-id pub-id-type="pmid">26180612</pub-id></element-citation></ref><ref id="b45-jos-2015-01739"><label>45</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bruzoni</surname><given-names>M</given-names></name><name><surname>Steinberg</surname><given-names>GK</given-names></name><name><surname>Dutta</surname><given-names>S</given-names></name></person-group><article-title>Laparoscopic harvesting of omental pedicle flap for cerebral revascularization in children with moyamoya disease</article-title><source>J Pediatr Surg</source><year>2015</year><volume>19</volume></element-citation></ref><ref id="b46-jos-2015-01739"><label>46</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Havlik</surname><given-names>RJ</given-names></name><name><surname>Fried</surname><given-names>I</given-names></name><name><surname>Chyatte</surname><given-names>D</given-names></name><name><surname>Modlin</surname><given-names>IM</given-names></name></person-group><article-title>Encephalo-omental synangiosis in the management of moyamoya disease</article-title><source>Surgery</source><year>1992</year><volume>111</volume><fpage>156</fpage><lpage>162</lpage><pub-id pub-id-type="pmid">1736385</pub-id></element-citation></ref><ref id="b47-jos-2015-01739"><label>47</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhao</surname><given-names>X</given-names></name><name><surname>Wang</surname><given-names>C</given-names></name><name><surname>Ji</surname><given-names>Y</given-names></name><name><surname>Han</surname><given-names>C</given-names></name><name><surname>Wang</surname><given-names>M</given-names></name></person-group><article-title>Therapeutic effect of multiple burr hole operation combined with dural inversion and periosteal synangiosis for moyamoya disease</article-title><source>Br J Neurosurg</source><year>2015</year><fpage>1</fpage><lpage>7</lpage></element-citation></ref><ref id="b48-jos-2015-01739"><label>48</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kawaguchi</surname><given-names>T</given-names></name><name><surname>Fujita</surname><given-names>S</given-names></name><name><surname>Hosoda</surname><given-names>K</given-names></name><name><surname>Shose</surname><given-names>Y</given-names></name><name><surname>Hamano</surname><given-names>S</given-names></name><name><surname>Iwakura</surname><given-names>M</given-names></name><etal/></person-group><article-title>Multiple burr-hole operation for adult moyamoya disease</article-title><source>J Neurosurg</source><year>1996</year><volume>84</volume><fpage>468</fpage><lpage>476</lpage><pub-id pub-id-type="pmid">8609560</pub-id></element-citation></ref><ref id="b49-jos-2015-01739"><label>49</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kazumata</surname><given-names>K</given-names></name><name><surname>Ito</surname><given-names>M</given-names></name><name><surname>Tokairin</surname><given-names>K</given-names></name><name><surname>Ito</surname><given-names>Y</given-names></name><name><surname>Houkin</surname><given-names>K</given-names></name><name><surname>Nakayama</surname><given-names>N</given-names></name><etal/></person-group><article-title>The frequency of postoperative stroke in moyamoya disease following combined revascularization: a single-university series and systematic review</article-title><source>J Neurosurg</source><year>2014</year><volume>121</volume><fpage>432</fpage><lpage>440</lpage><pub-id pub-id-type="pmid">24605834</pub-id></element-citation></ref><ref id="b50-jos-2015-01739"><label>50</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Funaki</surname><given-names>T</given-names></name><name><surname>Takahashi</surname><given-names>JC</given-names></name><name><surname>Takagi</surname><given-names>Y</given-names></name><name><surname>Kikuchi</surname><given-names>T</given-names></name><name><surname>Yoshida</surname><given-names>K</given-names></name><name><surname>Mitsuhara</surname><given-names>T</given-names></name><etal/></person-group><article-title>Unstable moyamoya disease: clinical features and impact on perioperative ischemic complications</article-title><source>J Neurosurg</source><year>2015</year><volume>122</volume><fpage>400</fpage><lpage>407</lpage><pub-id pub-id-type="pmid">25423271</pub-id></element-citation></ref><ref id="b51-jos-2015-01739"><label>51</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Choi</surname><given-names>H</given-names></name><name><surname>Lee</surname><given-names>JY</given-names></name><name><surname>Phi</surname><given-names>JH</given-names></name><name><surname>Kim</surname><given-names>SK</given-names></name><name><surname>Cho</surname><given-names>BK</given-names></name><name><surname>Wang</surname><given-names>KC</given-names></name></person-group><article-title>Postoperative epidural hematoma covering the galeal flap in pediatric patients with moyamoya disease: clinical manifestation, risk factors, and outcomes</article-title><source>J Neurosurg Pediatr</source><year>2013</year><volume>12</volume><fpage>181</fpage><lpage>186</lpage><pub-id pub-id-type="pmid">23746127</pub-id></element-citation></ref><ref id="b52-jos-2015-01739"><label>52</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fujimura</surname><given-names>M</given-names></name><name><surname>Kaneta</surname><given-names>T</given-names></name><name><surname>Mugikura</surname><given-names>S</given-names></name><name><surname>Shimizu</surname><given-names>H</given-names></name><name><surname>Tominaga</surname><given-names>T</given-names></name></person-group><article-title>Temporary neurologic deterioration due to cerebral hyperperfusion after superficial temporal artery-middle cerebral artery anastomosis in patients with adult-onset moyamoya disease</article-title><source>Surg Neurol</source><year>2007</year><volume>67</volume><fpage>273</fpage><lpage>282</lpage><pub-id pub-id-type="pmid">17320638</pub-id></element-citation></ref><ref id="b53-jos-2015-01739"><label>53</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fujimura</surname><given-names>M</given-names></name><name><surname>Shimizu</surname><given-names>H</given-names></name><name><surname>Inoue</surname><given-names>T</given-names></name><name><surname>Mugikura</surname><given-names>S</given-names></name><name><surname>Saito</surname><given-names>A</given-names></name><name><surname>Tominaga</surname><given-names>T</given-names></name></person-group><article-title>Significance of focal cerebral hyperperfusion as a cause of transient neurologic deterioration after extracranial-intracranial bypass for moyamoya disease: comparative study with non-moyamoya patients using N-isopropyl-p-[(123)I]iodoamphetamine single-photon emission computed tomography</article-title><source>Neurosurgery</source><year>2011</year><volume>68</volume><fpage>957</fpage><lpage>964</lpage><pub-id pub-id-type="pmid">21221039</pub-id></element-citation></ref><ref id="b54-jos-2015-01739"><label>54</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Uchino</surname><given-names>H</given-names></name><name><surname>Kuroda</surname><given-names>S</given-names></name><name><surname>Hirata</surname><given-names>K</given-names></name><name><surname>Shiga</surname><given-names>T</given-names></name><name><surname>Houkin</surname><given-names>K</given-names></name><name><surname>Tamaki</surname><given-names>N</given-names></name></person-group><article-title>Predictors and clinical features of postoperative hyperperfusion after surgical revascularization for moyamoya disease: a serial single photon emission CT/positron emission tomography study</article-title><source>Stroke</source><year>2012</year><volume>43</volume><fpage>2610</fpage><lpage>2616</lpage><pub-id pub-id-type="pmid">22871684</pub-id></element-citation></ref><ref id="b55-jos-2015-01739"><label>55</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kim</surname><given-names>JE</given-names></name><name><surname>Oh</surname><given-names>CW</given-names></name><name><surname>Kwon</surname><given-names>OK</given-names></name><name><surname>Park</surname><given-names>SQ</given-names></name><name><surname>Kim</surname><given-names>SE</given-names></name><name><surname>Kim</surname><given-names>YK</given-names></name></person-group><article-title>Transient hyperperfusion after superficial temporal artery/middle cerebral artery bypass surgery as a possible cause of postoperative transient neurological deterioration</article-title><source>Cerebrovasc Dis</source><year>2008</year><volume>25</volume><fpage>580</fpage><lpage>586</lpage><pub-id pub-id-type="pmid">18483458</pub-id></element-citation></ref><ref id="b56-jos-2015-01739"><label>56</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hayashi</surname><given-names>K</given-names></name><name><surname>Horie</surname><given-names>N</given-names></name><name><surname>Suyama</surname><given-names>K</given-names></name><name><surname>Nagata</surname><given-names>I</given-names></name></person-group><article-title>Incidence and clinical features of symptomatic cerebral hyperperfusion syndrome after vascular reconstruction</article-title><source>World Neurosurg</source><year>2012</year><volume>78</volume><fpage>447</fpage><lpage>454</lpage><pub-id pub-id-type="pmid">22120558</pub-id></element-citation></ref><ref id="b57-jos-2015-01739"><label>57</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Katsuta</surname><given-names>T</given-names></name><name><surname>Inoue</surname><given-names>T</given-names></name><name><surname>Arakawa</surname><given-names>S</given-names></name><name><surname>Uda</surname><given-names>K</given-names></name></person-group><article-title>Cutaneous necrosis after superficial temporal artery-to-middle cerebral artery anastomosis: is it predictable or avoidable?</article-title><source>Neurosurgery</source><year>2001</year><volume>49</volume><fpage>879</fpage><lpage>882</lpage><pub-id pub-id-type="pmid">11564249</pub-id></element-citation></ref><ref id="b58-jos-2015-01739"><label>58</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Takanari</surname><given-names>K</given-names></name><name><surname>Araki</surname><given-names>Y</given-names></name><name><surname>Okamoto</surname><given-names>S</given-names></name><name><surname>Sato</surname><given-names>H</given-names></name><name><surname>Yagi</surname><given-names>S</given-names></name><name><surname>Toriyama</surname><given-names>K</given-names></name><etal/></person-group><article-title>Operative wound-related complications after cranial revascularization surgeries</article-title><source>J Neurosurg</source><year>2015</year><fpage>1</fpage><lpage>6</lpage><pub-id pub-id-type="pmid">26140494</pub-id></element-citation></ref><ref id="b59-jos-2015-01739"><label>59</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Arias</surname><given-names>EJ</given-names></name><name><surname>Dunn</surname><given-names>GP</given-names></name><name><surname>Washington</surname><given-names>CW</given-names></name><name><surname>Derdeyn</surname><given-names>CP</given-names></name><name><surname>Chicoine</surname><given-names>MR</given-names></name><name><surname>Grubb</surname><given-names>RL</given-names><suffix>Jr.</suffix></name><etal/></person-group><article-title>Surgical Revascularization in North American Adults with Moyamoya Phenomenon: Long-Term Angiographic Follow-up</article-title><source>J Stroke Cerebrovasc Dis</source><year>2015</year><volume>24</volume><fpage>1597</fpage><lpage>1608</lpage><pub-id pub-id-type="pmid">25972283</pub-id></element-citation></ref><ref id="b60-jos-2015-01739"><label>60</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bao</surname><given-names>XY</given-names></name><name><surname>Duan</surname><given-names>L</given-names></name><name><surname>Li</surname><given-names>DS</given-names></name><name><surname>Yang</surname><given-names>WZ</given-names></name><name><surname>Sun</surname><given-names>WJ</given-names></name><name><surname>Zhang</surname><given-names>ZS</given-names></name><etal/></person-group><article-title>Clinical features, surgical treatment and long-term outcome in adult patients with Moyamoya disease in China</article-title><source>Cerebrovasc Dis</source><year>2012</year><volume>34</volume><fpage>305</fpage><lpage>313</lpage><pub-id pub-id-type="pmid">23146868</pub-id></element-citation></ref><ref id="b61-jos-2015-01739"><label>61</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bao</surname><given-names>XY</given-names></name><name><surname>Duan</surname><given-names>L</given-names></name><name><surname>Yang</surname><given-names>WZ</given-names></name><name><surname>Li</surname><given-names>DS</given-names></name><name><surname>Sun</surname><given-names>WJ</given-names></name><name><surname>Zhang</surname><given-names>ZS</given-names></name><etal/></person-group><article-title>Clinical features, surgical treatment, and long-term outcome in pediatric patients with moyamoya disease in China</article-title><source>Cerebrovasc Dis</source><year>2015</year><volume>39</volume><fpage>75</fpage><lpage>81</lpage><pub-id pub-id-type="pmid">25573764</pub-id></element-citation></ref><ref id="b62-jos-2015-01739"><label>62</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Funaki</surname><given-names>T</given-names></name><name><surname>Takahashi</surname><given-names>JC</given-names></name><name><surname>Takagi</surname><given-names>Y</given-names></name><name><surname>Yoshida</surname><given-names>K</given-names></name><name><surname>Araki</surname><given-names>Y</given-names></name><name><surname>Kikuchi</surname><given-names>T</given-names></name><etal/></person-group><article-title>Incidence of late cerebrovascular events after direct bypass among children with moyamoya disease: a descriptive longitudinal study at a single center</article-title><source>Acta Neurochir (Wien)</source><year>2014</year><volume>156</volume><fpage>551</fpage><lpage>559</lpage><pub-id pub-id-type="pmid">24363147</pub-id></element-citation></ref><ref id="b63-jos-2015-01739"><label>63</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Goda</surname><given-names>M</given-names></name><name><surname>Isono</surname><given-names>M</given-names></name><name><surname>Ishii</surname><given-names>K</given-names></name><name><surname>Kamida</surname><given-names>T</given-names></name><name><surname>Abe</surname><given-names>T</given-names></name><name><surname>Kobayashi</surname><given-names>H</given-names></name></person-group><article-title>Long-term effects of indirect bypass surgery on collateral vessel formation in pediatric moyamoya disease</article-title><source>J Neurosurg</source><year>2004</year><volume>100</volume><fpage>156</fpage><lpage>162</lpage><pub-id pub-id-type="pmid">14758943</pub-id></element-citation></ref><ref id="b64-jos-2015-01739"><label>64</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gross</surname><given-names>BA</given-names></name><name><surname>Du</surname><given-names>R</given-names></name></person-group><article-title>Adult moyamoya after revascularization</article-title><source>Acta Neurochir (Wien)</source><year>2013</year><volume>155</volume><fpage>247</fpage><lpage>254</lpage><pub-id pub-id-type="pmid">23108563</pub-id></element-citation></ref><ref id="b65-jos-2015-01739"><label>65</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Imai</surname><given-names>H</given-names></name><name><surname>Miyawaki</surname><given-names>S</given-names></name><name><surname>Ono</surname><given-names>H</given-names></name><name><surname>Nakatomi</surname><given-names>H</given-names></name><name><surname>Yoshimoto</surname><given-names>Y</given-names></name><name><surname>Saito</surname><given-names>N</given-names></name></person-group><article-title>The importance of encephalo-myo-synangiosis in surgical revascularization strategies for moyamoya disease in children and adults</article-title><source>World Neurosurg</source><year>2015</year><volume>83</volume><fpage>691</fpage><lpage>699</lpage><pub-id pub-id-type="pmid">25655688</pub-id></element-citation></ref><ref id="b66-jos-2015-01739"><label>66</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Karasawa</surname><given-names>J</given-names></name><name><surname>Touho</surname><given-names>H</given-names></name><name><surname>Ohnishi</surname><given-names>H</given-names></name><name><surname>Miyamoto</surname><given-names>S</given-names></name><name><surname>Kikuchi</surname><given-names>H</given-names></name></person-group><article-title>Long-term follow-up study after extracranial-intracranial bypass surgery for anterior circulation ischemia in childhood moyamoya disease</article-title><source>J Neurosurg</source><year>1992</year><volume>77</volume><fpage>84</fpage><lpage>89</lpage><pub-id pub-id-type="pmid">1607976</pub-id></element-citation></ref><ref id="b67-jos-2015-01739"><label>67</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kuroda</surname><given-names>S</given-names></name><name><surname>Houkin</surname><given-names>K</given-names></name><name><surname>Ishikawa</surname><given-names>T</given-names></name><name><surname>Nakayama</surname><given-names>N</given-names></name><name><surname>Iwasaki</surname><given-names>Y</given-names></name></person-group><article-title>Novel bypass surgery for moyamoya disease using pericranial flap: its impacts on cerebral hemodynamics and long-term outcome</article-title><source>Neurosurgery</source><year>2010</year><volume>66</volume><fpage>1093</fpage><lpage>1101</lpage><pub-id pub-id-type="pmid">20495424</pub-id></element-citation></ref><ref id="b68-jos-2015-01739"><label>68</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Scott</surname><given-names>RM</given-names></name><name><surname>Smith</surname><given-names>JL</given-names></name><name><surname>Robertson</surname><given-names>RL</given-names></name><name><surname>Madsen</surname><given-names>JR</given-names></name><name><surname>Soriano</surname><given-names>SG</given-names></name><name><surname>Rockoff</surname><given-names>MA</given-names></name></person-group><article-title>Long-term outcome in children with moyamoya syndrome after cranial revascularization by pial synangiosis</article-title><source>J Neurosurg</source><year>2004</year><volume>100</volume><fpage>142</fpage><lpage>149</lpage><pub-id pub-id-type="pmid">14758941</pub-id></element-citation></ref><ref id="b69-jos-2015-01739"><label>69</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Han</surname><given-names>JS</given-names></name><name><surname>Abou-Hamden</surname><given-names>A</given-names></name><name><surname>Mandell</surname><given-names>DM</given-names></name><name><surname>Poublanc</surname><given-names>J</given-names></name><name><surname>Crawley</surname><given-names>AP</given-names></name><name><surname>Fisher</surname><given-names>JA</given-names></name><etal/></person-group><article-title>Impact of extracranial-intracranial bypass on cerebrovascular reactivity and clinical outcome in patients with symptomatic moyamoya vasculopathy</article-title><source>Stroke</source><year>2011</year><volume>42</volume><fpage>3047</fpage><lpage>3054</lpage><pub-id pub-id-type="pmid">21903951</pub-id></element-citation></ref><ref id="b70-jos-2015-01739"><label>70</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Phi</surname><given-names>JH</given-names></name><name><surname>Wang</surname><given-names>KC</given-names></name><name><surname>Cho</surname><given-names>BK</given-names></name><name><surname>Lee</surname><given-names>MS</given-names></name><name><surname>Lee</surname><given-names>JH</given-names></name><name><surname>Yu</surname><given-names>KS</given-names></name><etal/></person-group><article-title>Long-term social outcome in children with moyamoya disease who have reached adulthood</article-title><source>J Neurosurg Pediatr</source><year>2011</year><volume>8</volume><fpage>303</fpage><lpage>309</lpage><pub-id pub-id-type="pmid">21882923</pub-id></element-citation></ref><ref id="b71-jos-2015-01739"><label>71</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shim</surname><given-names>KW</given-names></name><name><surname>Park</surname><given-names>EK</given-names></name><name><surname>Kim</surname><given-names>JS</given-names></name><name><surname>Kim</surname><given-names>DS</given-names></name></person-group><article-title>Cognitive Outcome of Pediatric Moyamoya Disease</article-title><source>J Korean Neurosurg Soc</source><year>2015</year><volume>57</volume><fpage>440</fpage><lpage>444</lpage><pub-id pub-id-type="pmid">26180613</pub-id></element-citation></ref><ref id="b72-jos-2015-01739"><label>72</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nakagawa</surname><given-names>Y</given-names></name><name><surname>Gotoh</surname><given-names>S</given-names></name><name><surname>Shimoyama</surname><given-names>M</given-names></name><name><surname>Ohtsuka</surname><given-names>K</given-names></name><name><surname>Mabuchi</surname><given-names>S</given-names></name><name><surname>Sawamura</surname><given-names>Y</given-names></name><etal/></person-group><article-title>Reconstructive operation for moyamoya disease. Surgical indication for the hemorrhagic type, and preferable operative methods</article-title><source>Neurol Med Chir (Tokyo)</source><year>1983</year><volume>23</volume><fpage>464</fpage><lpage>470</lpage><pub-id pub-id-type="pmid">6195542</pub-id></element-citation></ref><ref id="b73-jos-2015-01739"><label>73</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Aoki</surname><given-names>N</given-names></name></person-group><article-title>Cerebrovascular bypass surgery for the treatment of Moyamoya disease: unsatisfactory outcome in the patients presenting with intracranial hemorrhage</article-title><source>Surg Neurol</source><year>1993</year><volume>40</volume><fpage>372</fpage><lpage>377</lpage><pub-id pub-id-type="pmid">8211652</pub-id></element-citation></ref><ref id="b74-jos-2015-01739"><label>74</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname><given-names>X</given-names></name><name><surname>Zhang</surname><given-names>D</given-names></name><name><surname>Shuo</surname><given-names>W</given-names></name><name><surname>Zhao</surname><given-names>Y</given-names></name><name><surname>Wang</surname><given-names>R</given-names></name><name><surname>Zhao</surname><given-names>J</given-names></name></person-group><article-title>Long term outcome after conservative and surgical treatment of haemorrhagic moyamoya disease</article-title><source>J Neurol Neurosurg Psychiatry</source><year>2013</year><volume>84</volume><fpage>258</fpage><lpage>265</lpage><pub-id pub-id-type="pmid">23012444</pub-id></element-citation></ref><ref id="b75-jos-2015-01739"><label>75</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ahn</surname><given-names>JH</given-names></name><name><surname>Wang</surname><given-names>KC</given-names></name><name><surname>Phi</surname><given-names>JH</given-names></name><name><surname>Lee</surname><given-names>JY</given-names></name><name><surname>Cho</surname><given-names>BK</given-names></name><name><surname>Kim</surname><given-names>IO</given-names></name><etal/></person-group><article-title>Hemorrhagic moyamoya disease in children: clinical features and surgical outcome</article-title><source>Childs Nerv Syst</source><year>2012</year><volume>28</volume><fpage>237</fpage><lpage>245</lpage><pub-id pub-id-type="pmid">21805358</pub-id></element-citation></ref></ref-list></back><floats-group><fig id="f1-jos-2015-01739" orientation="portrait" position="float"><label>Figure 1.</label><caption><p>This line charts demonstrates the change in the number of revascularization surgeries from 2009 to 2013 in Korea. The number of indirect revascularization surgeries is constant over this period while the number of direct revascularization surgeries gradually increases.</p></caption><graphic xlink:href="jos-2015-01739f1"/></fig><fig id="f2-jos-2015-01739" orientation="portrait" position="float"><label>Figure 2.</label><caption><p>Post-operative angiography of the external carotid artery. Black arrowheads indicate the superficial temporal artery (donor artery). The tip of the black arrow is the anastomosis site to the angular artery (recipient artery). The middle cerebral artery is supplied from the superficial temporal artery with a reverse direction (white arrowheads).</p></caption><graphic xlink:href="jos-2015-01739f2"/></fig><fig id="f3-jos-2015-01739" orientation="portrait" position="float"><label>Figure 3.</label><caption><p>The quantitative magnetic resonance angiography shows intact bypass flow through the superficial temporal artery.</p></caption><graphic xlink:href="jos-2015-01739f3"/></fig><fig id="f4-jos-2015-01739" orientation="portrait" position="float"><label>Figure 4.</label><caption><p>Intraoperative photos show the surgical procedure of encephalo-duro-arterio synangiosis (EDAS). (A) The formation of the arterial flap containing the parietal branch of the superficial temporal artery (STA) and surrounding galea tissue as a cuff shape. Under the flap, the cortex is exposed through the ovoid craniotomy and durotomy. (B) Completed suture with dural margin. The proximal and distal end of the STA is kept connected without cutting (white arrowheads=the parietal branch of the STA; black arrowheads=the dural margin being sutured with the cuff of flap water-tightly; asterisk=the temporalis muscle split vertically and reflected).</p></caption><graphic xlink:href="jos-2015-01739f4"/></fig><fig id="f5-jos-2015-01739" orientation="portrait" position="float"><label>Figure 5.</label><caption><p>Post-operative single-photon emission computed tomography showing improved vascular reserve in the Diamox study comparing the pre-operative status.</p></caption><graphic xlink:href="jos-2015-01739f5"/></fig><table-wrap id="t1-jos-2015-01739" orientation="portrait" position="float"><label>Table 1.</label><caption><p>Literature reporting post-operative stroke development after revascularization</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" valign="middle" rowspan="1" colspan="1">Authors</th><th align="center" valign="middle" rowspan="1" colspan="1">Year</th><th align="center" valign="middle" rowspan="1" colspan="1">Number of patients</th><th align="center" valign="middle" rowspan="1" colspan="1">Post-operative stroke</th><th align="center" valign="middle" rowspan="1" colspan="1">Follow-up Duration (month)</th><th align="center" valign="middle" rowspan="1" colspan="1">Annual stroke rate</th></tr></thead><tbody><tr><td align="left" valign="top" rowspan="1" colspan="1">Direct revascularization for adults</td><td align="center" valign="top" rowspan="1" colspan="1"/><td align="center" valign="top" rowspan="1" colspan="1"/><td align="center" valign="top" rowspan="1" colspan="1"/><td align="center" valign="top" rowspan="1" colspan="1"/><td align="center" valign="top" rowspan="1" colspan="1"/></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">&#x02003;Kuroda et al. [<xref rid="b67-jos-2015-01739" ref-type="bibr">67</xref>]</td><td align="center" valign="top" rowspan="1" colspan="1">2010</td><td align="center" valign="top" rowspan="1" colspan="1">47</td><td align="center" valign="top" rowspan="1" colspan="1">1</td><td align="center" valign="top" rowspan="1" colspan="1">63</td><td align="center" valign="top" rowspan="1" colspan="1">0.4</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">&#x02003;Bang et al. [<xref rid="b26-jos-2015-01739" ref-type="bibr">26</xref>]</td><td align="center" valign="top" rowspan="1" colspan="1">2012</td><td align="center" valign="top" rowspan="1" colspan="1">61</td><td align="center" valign="top" rowspan="1" colspan="1">1</td><td align="center" valign="top" rowspan="1" colspan="1">64</td><td align="center" valign="top" rowspan="1" colspan="1">0.3</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">&#x02003;Gross et al. [<xref rid="b64-jos-2015-01739" ref-type="bibr">64</xref>]</td><td align="center" valign="top" rowspan="1" colspan="1">2013</td><td align="center" valign="top" rowspan="1" colspan="1">29</td><td align="center" valign="top" rowspan="1" colspan="1">2</td><td align="center" valign="top" rowspan="1" colspan="1"/><td align="center" valign="top" rowspan="1" colspan="1">5.4</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">&#x02003;Cho et al. [<xref rid="b24-jos-2015-01739" ref-type="bibr">24</xref>]</td><td align="center" valign="top" rowspan="1" colspan="1">2014</td><td align="center" valign="top" rowspan="1" colspan="1">60</td><td align="center" valign="top" rowspan="1" colspan="1">3</td><td align="center" valign="top" rowspan="1" colspan="1">71</td><td align="center" valign="top" rowspan="1" colspan="1">0.8</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">&#x02003;Kim et al. [<xref rid="b6-jos-2015-01739" ref-type="bibr">6</xref>]</td><td align="center" valign="top" rowspan="1" colspan="1">2015</td><td align="center" valign="top" rowspan="1" colspan="1">301</td><td align="center" valign="top" rowspan="1" colspan="1">18</td><td align="center" valign="top" rowspan="1" colspan="1">45</td><td align="center" valign="top" rowspan="1" colspan="1">1.6</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">&#x02003;Arias et al. [<xref rid="b59-jos-2015-01739" ref-type="bibr">59</xref>]</td><td align="center" valign="top" rowspan="1" colspan="1">2015</td><td align="center" valign="top" rowspan="1" colspan="1">6</td><td align="center" valign="top" rowspan="1" colspan="1">0</td><td align="center" valign="top" rowspan="1" colspan="1">36</td><td align="center" valign="top" rowspan="1" colspan="1">0.0</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">&#x02003;Sum</td><td align="center" valign="top" rowspan="1" colspan="1"/><td align="center" valign="top" rowspan="1" colspan="1">504</td><td align="center" valign="top" rowspan="1" colspan="1">25</td><td align="center" valign="top" rowspan="1" colspan="1"/><td align="center" valign="top" rowspan="1" colspan="1">1.4<sup><xref rid="tfn1-jos-2015-01739" ref-type="table-fn">*</xref></sup></td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Direct revascularization for children</td><td align="center" valign="top" rowspan="1" colspan="1"/><td align="center" valign="top" rowspan="1" colspan="1"/><td align="center" valign="top" rowspan="1" colspan="1"/><td align="center" valign="top" rowspan="1" colspan="1"/><td align="center" valign="top" rowspan="1" colspan="1"/></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">&#x02003;Karasawa et al. [<xref rid="b66-jos-2015-01739" ref-type="bibr">66</xref>]</td><td align="center" valign="top" rowspan="1" colspan="1">1992</td><td align="center" valign="top" rowspan="1" colspan="1">104</td><td align="center" valign="top" rowspan="1" colspan="1">2</td><td align="center" valign="top" rowspan="1" colspan="1">115</td><td align="center" valign="top" rowspan="1" colspan="1">0.2</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">&#x02003;Kuroda et al. [<xref rid="b67-jos-2015-01739" ref-type="bibr">67</xref>]</td><td align="center" valign="top" rowspan="1" colspan="1">2010</td><td align="center" valign="top" rowspan="1" colspan="1">28</td><td align="center" valign="top" rowspan="1" colspan="1">0</td><td align="center" valign="top" rowspan="1" colspan="1">73</td><td align="center" valign="top" rowspan="1" colspan="1">0.0</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">&#x02003;Funaki et al. [<xref rid="b62-jos-2015-01739" ref-type="bibr">62</xref>]</td><td align="center" valign="top" rowspan="1" colspan="1">2014</td><td align="center" valign="top" rowspan="1" colspan="1">58</td><td align="center" valign="top" rowspan="1" colspan="1">4</td><td align="center" valign="top" rowspan="1" colspan="1">217</td><td align="center" valign="top" rowspan="1" colspan="1">0.4</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">&#x02003;Sum</td><td align="center" valign="top" rowspan="1" colspan="1"/><td align="center" valign="top" rowspan="1" colspan="1">190</td><td align="center" valign="top" rowspan="1" colspan="1">6</td><td align="center" valign="top" rowspan="1" colspan="1"/><td align="center" valign="top" rowspan="1" colspan="1">0.2<sup><xref rid="tfn1-jos-2015-01739" ref-type="table-fn">*</xref></sup></td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Indirect revascularization for adults</td><td align="center" valign="top" rowspan="1" colspan="1"/><td align="center" valign="top" rowspan="1" colspan="1"/><td align="center" valign="top" rowspan="1" colspan="1"/><td align="center" valign="top" rowspan="1" colspan="1"/><td align="center" valign="top" rowspan="1" colspan="1"/></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">&#x02003;Bang et al. [<xref rid="b26-jos-2015-01739" ref-type="bibr">26</xref>]</td><td align="center" valign="top" rowspan="1" colspan="1">2012</td><td align="center" valign="top" rowspan="1" colspan="1">14</td><td align="center" valign="top" rowspan="1" colspan="1">2</td><td align="center" valign="top" rowspan="1" colspan="1">64</td><td align="center" valign="top" rowspan="1" colspan="1">2.7</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">&#x02003;Bao et al. [<xref rid="b60-jos-2015-01739" ref-type="bibr">60</xref>]</td><td align="center" valign="top" rowspan="1" colspan="1">2012</td><td align="center" valign="top" rowspan="1" colspan="1">470</td><td align="center" valign="top" rowspan="1" colspan="1">60</td><td align="center" valign="top" rowspan="1" colspan="1">27</td><td align="center" valign="top" rowspan="1" colspan="1">5.8</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">&#x02003;Gross et al. [<xref rid="b64-jos-2015-01739" ref-type="bibr">64</xref>]</td><td align="center" valign="top" rowspan="1" colspan="1">2013</td><td align="center" valign="top" rowspan="1" colspan="1">13</td><td align="center" valign="top" rowspan="1" colspan="1">5</td><td align="center" valign="top" rowspan="1" colspan="1"/><td align="center" valign="top" rowspan="1" colspan="1">14.3</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">&#x02003;Imai et al. [<xref rid="b65-jos-2015-01739" ref-type="bibr">65</xref>]</td><td align="center" valign="top" rowspan="1" colspan="1">2015</td><td align="center" valign="top" rowspan="1" colspan="1">36</td><td align="center" valign="top" rowspan="1" colspan="1">1</td><td align="center" valign="top" rowspan="1" colspan="1">72</td><td align="center" valign="top" rowspan="1" colspan="1">0.5</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">&#x02003;Arias et al. [<xref rid="b59-jos-2015-01739" ref-type="bibr">59</xref>]</td><td align="center" valign="top" rowspan="1" colspan="1">2015</td><td align="center" valign="top" rowspan="1" colspan="1">9</td><td align="center" valign="top" rowspan="1" colspan="1">0</td><td align="center" valign="top" rowspan="1" colspan="1">36</td><td align="center" valign="top" rowspan="1" colspan="1">0.0</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">&#x02003;Noh et al. [<xref rid="b18-jos-2015-01739" ref-type="bibr">18</xref>]</td><td align="center" valign="top" rowspan="1" colspan="1">2015</td><td align="center" valign="top" rowspan="1" colspan="1">45</td><td align="center" valign="top" rowspan="1" colspan="1">12</td><td align="center" valign="top" rowspan="1" colspan="1">46</td><td align="center" valign="top" rowspan="1" colspan="1">7.0</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">&#x02003;Sum</td><td align="center" valign="top" rowspan="1" colspan="1"/><td align="center" valign="top" rowspan="1" colspan="1">587</td><td align="center" valign="top" rowspan="1" colspan="1">80</td><td align="center" valign="top" rowspan="1" colspan="1"/><td align="center" valign="top" rowspan="1" colspan="1">5.6<sup><xref rid="tfn1-jos-2015-01739" ref-type="table-fn">*</xref></sup></td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Indirect revascularization for children</td><td align="center" valign="top" rowspan="1" colspan="1"/><td align="center" valign="top" rowspan="1" colspan="1"/><td align="center" valign="top" rowspan="1" colspan="1"/><td align="center" valign="top" rowspan="1" colspan="1"/><td align="center" valign="top" rowspan="1" colspan="1"/></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">&#x02003;Goda et al. [<xref rid="b63-jos-2015-01739" ref-type="bibr">63</xref>]</td><td align="center" valign="top" rowspan="1" colspan="1">2004</td><td align="center" valign="top" rowspan="1" colspan="1">23</td><td align="center" valign="top" rowspan="1" colspan="1">0</td><td align="center" valign="top" rowspan="1" colspan="1">144</td><td align="center" valign="top" rowspan="1" colspan="1">0.0</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">&#x02003;Scott et al. [<xref rid="b68-jos-2015-01739" ref-type="bibr">68</xref>]</td><td align="center" valign="top" rowspan="1" colspan="1">2004</td><td align="center" valign="top" rowspan="1" colspan="1">126</td><td align="center" valign="top" rowspan="1" colspan="1">15</td><td align="center" valign="top" rowspan="1" colspan="1">61</td><td align="center" valign="top" rowspan="1" colspan="1">2.3</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">&#x02003;Imai et al. [<xref rid="b65-jos-2015-01739" ref-type="bibr">65</xref>]</td><td align="center" valign="top" rowspan="1" colspan="1">2015</td><td align="center" valign="top" rowspan="1" colspan="1">29</td><td align="center" valign="top" rowspan="1" colspan="1">0</td><td align="center" valign="top" rowspan="1" colspan="1">90</td><td align="center" valign="top" rowspan="1" colspan="1">0.0</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">&#x02003;Bao et al. [<xref rid="b61-jos-2015-01739" ref-type="bibr">61</xref>]</td><td align="center" valign="top" rowspan="1" colspan="1">2015</td><td align="center" valign="top" rowspan="1" colspan="1">288</td><td align="center" valign="top" rowspan="1" colspan="1">20</td><td align="center" valign="top" rowspan="1" colspan="1">52</td><td align="center" valign="top" rowspan="1" colspan="1">1.6</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">&#x02003;Sum</td><td align="center" valign="top" rowspan="1" colspan="1"/><td align="center" valign="top" rowspan="1" colspan="1">466</td><td align="center" valign="top" rowspan="1" colspan="1">35</td><td align="center" valign="top" rowspan="1" colspan="1"/><td align="center" valign="top" rowspan="1" colspan="1">1.6<sup><xref rid="tfn1-jos-2015-01739" ref-type="table-fn">*</xref></sup></td></tr></tbody></table><table-wrap-foot><fn id="tfn1-jos-2015-01739"><label>*</label><p>The overall annual incidence was calculated with the weighted average.</p></fn></table-wrap-foot></table-wrap></floats-group></article>